Cargando…

Modulation of Z-scheme photocatalysts for pharmaceuticals remediation and pathogen inactivation: Design devotion, concept examination, and developments

The recent outbreak of Covid-19 guarantees overconsumption of different drugs as a necessity to reduce the symptoms caused by this pandemic. This triggers the proliferation of pharmaceuticals into drinking water systems. Is there any hope for access to safe drinking water? Photocatalytic degradation...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwin Malefane, Mope, John Mafa, Potlako, Thokozani Innocent Nkambule, Thabo, Elizabeth Managa, Muthumuni, Tawanda Kuvarega, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422400/
https://www.ncbi.nlm.nih.gov/pubmed/36060035
http://dx.doi.org/10.1016/j.cej.2022.138894
_version_ 1784777803381604352
author Edwin Malefane, Mope
John Mafa, Potlako
Thokozani Innocent Nkambule, Thabo
Elizabeth Managa, Muthumuni
Tawanda Kuvarega, Alex
author_facet Edwin Malefane, Mope
John Mafa, Potlako
Thokozani Innocent Nkambule, Thabo
Elizabeth Managa, Muthumuni
Tawanda Kuvarega, Alex
author_sort Edwin Malefane, Mope
collection PubMed
description The recent outbreak of Covid-19 guarantees overconsumption of different drugs as a necessity to reduce the symptoms caused by this pandemic. This triggers the proliferation of pharmaceuticals into drinking water systems. Is there any hope for access to safe drinking water? Photocatalytic degradation using artificial Z-scheme photocatalysts that has been employed for over a decade conveys a prospect for sustainable clean water supply. It is compelling to comprehensively summarise the state-of-the-art effects of Z-scheme photocatalytic systems towards the removal of pharmaceuticals in water. The principle of Z-scheme and the techniques used to validate the Z-scheme interfacial charge transfer are explored in detail. The application of the Z-scheme photocatalysts towards the degradation of antibiotics, NSAIDs, and bacterial/viral inactivation is deliberated. Conclusions and stimulating standpoints on the challenges of this emergent research direction are presented. The insights and up-to-date information will prompt the up-scaling of Z- scheme photocatalytic systems for commercialization.
format Online
Article
Text
id pubmed-9422400
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-94224002022-08-30 Modulation of Z-scheme photocatalysts for pharmaceuticals remediation and pathogen inactivation: Design devotion, concept examination, and developments Edwin Malefane, Mope John Mafa, Potlako Thokozani Innocent Nkambule, Thabo Elizabeth Managa, Muthumuni Tawanda Kuvarega, Alex Chem Eng J Review The recent outbreak of Covid-19 guarantees overconsumption of different drugs as a necessity to reduce the symptoms caused by this pandemic. This triggers the proliferation of pharmaceuticals into drinking water systems. Is there any hope for access to safe drinking water? Photocatalytic degradation using artificial Z-scheme photocatalysts that has been employed for over a decade conveys a prospect for sustainable clean water supply. It is compelling to comprehensively summarise the state-of-the-art effects of Z-scheme photocatalytic systems towards the removal of pharmaceuticals in water. The principle of Z-scheme and the techniques used to validate the Z-scheme interfacial charge transfer are explored in detail. The application of the Z-scheme photocatalysts towards the degradation of antibiotics, NSAIDs, and bacterial/viral inactivation is deliberated. Conclusions and stimulating standpoints on the challenges of this emergent research direction are presented. The insights and up-to-date information will prompt the up-scaling of Z- scheme photocatalytic systems for commercialization. Elsevier B.V. 2023-01-15 2022-08-29 /pmc/articles/PMC9422400/ /pubmed/36060035 http://dx.doi.org/10.1016/j.cej.2022.138894 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Edwin Malefane, Mope
John Mafa, Potlako
Thokozani Innocent Nkambule, Thabo
Elizabeth Managa, Muthumuni
Tawanda Kuvarega, Alex
Modulation of Z-scheme photocatalysts for pharmaceuticals remediation and pathogen inactivation: Design devotion, concept examination, and developments
title Modulation of Z-scheme photocatalysts for pharmaceuticals remediation and pathogen inactivation: Design devotion, concept examination, and developments
title_full Modulation of Z-scheme photocatalysts for pharmaceuticals remediation and pathogen inactivation: Design devotion, concept examination, and developments
title_fullStr Modulation of Z-scheme photocatalysts for pharmaceuticals remediation and pathogen inactivation: Design devotion, concept examination, and developments
title_full_unstemmed Modulation of Z-scheme photocatalysts for pharmaceuticals remediation and pathogen inactivation: Design devotion, concept examination, and developments
title_short Modulation of Z-scheme photocatalysts for pharmaceuticals remediation and pathogen inactivation: Design devotion, concept examination, and developments
title_sort modulation of z-scheme photocatalysts for pharmaceuticals remediation and pathogen inactivation: design devotion, concept examination, and developments
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422400/
https://www.ncbi.nlm.nih.gov/pubmed/36060035
http://dx.doi.org/10.1016/j.cej.2022.138894
work_keys_str_mv AT edwinmalefanemope modulationofzschemephotocatalystsforpharmaceuticalsremediationandpathogeninactivationdesigndevotionconceptexaminationanddevelopments
AT johnmafapotlako modulationofzschemephotocatalystsforpharmaceuticalsremediationandpathogeninactivationdesigndevotionconceptexaminationanddevelopments
AT thokozaniinnocentnkambulethabo modulationofzschemephotocatalystsforpharmaceuticalsremediationandpathogeninactivationdesigndevotionconceptexaminationanddevelopments
AT elizabethmanagamuthumuni modulationofzschemephotocatalystsforpharmaceuticalsremediationandpathogeninactivationdesigndevotionconceptexaminationanddevelopments
AT tawandakuvaregaalex modulationofzschemephotocatalystsforpharmaceuticalsremediationandpathogeninactivationdesigndevotionconceptexaminationanddevelopments